| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 4672 | 2015 |
| The mPower study, Parkinson disease mobile data collected using ResearchKit BM Bot, C Suver, EC Neto, M Kellen, A Klein, C Bare, M Doerr, A Pratap, ... Scientific data 3 (1), 1-9, 2016 | 586 | 2016 |
| Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes FA Sinicrope, Q Shi, TC Smyrk, SN Thibodeau, R Dienstmann, J Guinney, ... Gastroenterology 148 (1), 88-99, 2015 | 365 | 2015 |
| Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ... Annals of Oncology 28 (5), 1023-1031, 2017 | 231 | 2017 |
| Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with … DJ Sargent, CH Köhne, HK Sanoff, BM Bot, MT Seymour, A De Gramont, ... Journal of Clinical Oncology 27 (12), 1948-1955, 2009 | 231 | 2009 |
| Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing Z Sun, YW Asmann, KR Kalari, B Bot, JE Eckel-Passow, TR Baker, ... PloS one 6 (2), e17490, 2011 | 190 | 2011 |
| Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials C Ferté, M Fernandez, A Hollebecque, S Koscielny, A Levy, C Massard, ... Clinical Cancer Research 20 (1), 246-252, 2014 | 180 | 2014 |
| Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open … J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ... The Lancet Oncology 18 (1), 132-142, 2017 | 160 | 2017 |
| Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors R Dienstmann, IS Jang, B Bot, S Friend, J Guinney Cancer discovery 5 (2), 118-123, 2015 | 140 | 2015 |
| Mobile health: the power of wearables, sensors, and apps to transform clinical trials B Munos, PC Baker, BM Bot, M Crouthamel, G de Vries, I Ferguson, ... Annals of the New York Academy of Sciences 1375 (1), 3-18, 2016 | 130 | 2016 |
| Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan … D Sargent, Q Shi, G Yothers, E Van Cutsem, J Cassidy, L Saltz, ... European journal of cancer 47 (7), 990-996, 2011 | 108 | 2011 |
| Remote smartphone monitoring of Parkinson’s disease and individual response to therapy L Omberg, E Chaibub Neto, TM Perumal, A Pratap, A Tediarjo, J Adams, ... Nature biotechnology 40 (4), 480-487, 2022 | 95 | 2022 |
| Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials CD Blanke, BM Bot, DM Thomas, A Bleyer, CH Kohne, MT Seymour, ... Journal of clinical oncology 29 (20), 2781-2786, 2011 | 84 | 2011 |
| Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer … A De Gramont, J Hubbard, Q Shi, MJ O'Connell, M Buyse, J Benedetti, ... Journal of clinical oncology 28 (3), 460-465, 2010 | 80 | 2010 |
| A large dataset of protein dynamics in the mammalian heart proteome E Lau, Q Cao, D Ng, BJ Bleakley, TU Dincer, BM Bot, D Wang, DA Liem, ... Scientific data 3 (1), 1-15, 2016 | 79 | 2016 |
| Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes TH Ho, DJ Serie, M Parasramka, JC Cheville, BM Bot, W Tan, L Wang, ... Annals of Oncology 28 (3), 604-610, 2017 | 77 | 2017 |
| Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the … Q Shi, T Andre, A Grothey, G Yothers, SR Hamilton, BM Bot, DG Haller, ... Journal of clinical oncology 31 (29), 3656-3663, 2013 | 76 | 2013 |
| The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit DE Webster, C Suver, M Doerr, E Mounts, L Domenico, T Petrie, ... Scientific data 4 (1), 1-8, 2017 | 70 | 2017 |
| Formative evaluation of participant experience with mobile eConsent in the app-mediated Parkinson mPower study: a mixed methods study M Doerr, AM Truong, BM Bot, J Wilbanks, C Suver, LM Mangravite JMIR mHealth and uHealth 5 (2), e6521, 2017 | 68 | 2017 |
| Detecting the impact of subject characteristics on machine learning-based diagnostic applications E Chaibub Neto, A Pratap, TM Perumal, M Tummalacherla, P Snyder, ... NPJ digital medicine 2 (1), 99, 2019 | 65 | 2019 |
Daniel SargentMayo Clinic在 mayo.edu 的电子邮件经过验证
